Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

55.80
Delayed Data
As of 4:00pm ET
 -0.32 / -0.57%
Today’s Change
37.38
Today|||52-Week Range
56.69
+45.27%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Operating ActivitiesNet Income / Starting Line798.0M419.0M283.0M603.0M
 
 
 
 
 
Depreciation319.0M774.0M648.0M756.0M
 
 
 
 
 
Total Other Cash Flow297.0M563.0M522.0M93.0M
 
 
 
 
 
Funds From Operations1.4B1.8B1.5B1.5B
 
 
 
 
 
Extraordinary Items0.00-1.2B0.00-12.0M
 
 
 
Funds From/For Other Operating Expenses244.0M31.0M102.0M-565.0M
 
 
 
 
 
Net Cash Flow - Operating Activities1.2B574.0M1.4B2.0B
 
 
 
 
 
 
InvestingIncrease In Investments-1.8B-15.0M-13.0M-70.0M
 
 
 
 
 
Decrease In Investments3.7B1.7B239.0M53.0M
 
 
 
 
 
Capital Expenditures-319.0M-272.0M-255.0M-263.0M
 
 
 
 
 
Fixed Asset Disposal0.005.5B-1.0M-29.0M
 
 
 
 
Net Assets From Acquisitions -7.0M-13.0B0.000.00
 
 
 
Other Investing - Sources8.0M3.0M24.0M3.0M
 
 
 
 
 
Net Cash Flow Investing1.6B-6.2B-6.0M-306.0M
 
 
 
 
 
 
FinancingShort Term Borrowings-1.1B-1.5B26.0M5.0M
 
 
 
 
 
Long Term Borrowings15.1B0.000.00-8.0M
 
 
 
Long Term Debt Reduction-1.0M-2.5B-2.0M-1.0M
 
 
 
 
 
Net Proceeds Stock Sale42.0M129.0M57.0M89.0M
 
 
 
 
 
Common Preferred Redeemed0.00-95.0M-3.0M-8.0M
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-386.0M-460.0M-462.0M-463.0M
 
 
 
 
 
Other Sources - Financing----------
Other Uses - Financing170.0M13.0M0.000.00
 
 
 
Net Cash Flow - Financing13.5B-4.4B-384.0M-386.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-104.0M65.0M8.0M24.0M
 
 
 
 
 
 
Net Change In Cash16.2B-10.0B961.0M1.3B